Aktis Oncology, Inc. Common stock Share Price
NASDAQ: AKTSHealthcare
Live Aktis Oncology, Inc. Common stock Share Price Chart
O H L
Aktis Oncology, Inc. Common stock Performance Overview
Days Range
▼
$22.55Low
$22.72High
Markets Today
| Previous Close | $22.86 |
|---|---|
| Open | $22.67 |
| Volume | 37,762 |
| Day's Range | $22.55 - $22.72 |
| 52W Range | $14.72 - $34.19 |
| Market Cap | $1.26 B |
Historical Performance
| 1M Returns | -8.56 |
|---|---|
| 3M Returns | -5.11 |
| 6M Returns | +25.05 |
| 1Y Returns | NA |
| 5Y Returns | +130.91 |
| 10Y Returns | NA |
Aktis Oncology, Inc. Common stock Fundamentals
| Market Cap | $1.26 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $27.38 M |
| ROE TTM | N/A |
| EPS TTM | $-1.42 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 2.59 |
| EBITDA | $-53.80 M |
| Profit Margin | -613.31 |
| Market Cap | $1.26 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $27.38 M |
| ROE TTM | N/A |
| EPS TTM | $-1.42 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 2.59 |
| EBITDA | $-53.80 M |
| Profit Margin | -613.31 |
Aktis Oncology, Inc. Common stock Profit & Loss
Quarterly
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $7.02 M | $7.51 M | $5.86 M | $9.03 M | $3.23 M | $3.38 M |
| Gross Profit + | $681.00 K | $349.00 K | -$635.00 K | $4.30 M | $3.23 M | $3.38 M |
| Operating Income | -$15.02 M | -$22.61 M | -$50.70 M | -$5.70 M | -$22.71 M | -$28.90 M |
| EBITDA | -$11.70 M | -$19.57 M | -$4.01 M | -$4.14 M | -$22.05 M | -$28.02 M |
| Interest Expense | -$679.00 K | -$745.00 K | -$749.00 K | -$713.00 K | $0 | $0 |
| Depreciation | $3.32 M | $3.04 M | $46.70 M | $1.56 M | $652.00 K | $879.00 K |
| Income Before Tax | -$15.71 M | -$23.31 M | -$108.80 M | -$6.42 M | -$18.32 M | -$24.14 M |
| Income Tax Expense | $2.00 K | $2.00 K | $1.00 K | $1.00 K | $0 | $0 |
| Net Income + | -$15.71 M | -$23.31 M | -$108.80 M | -$6.42 M | -$18.32 M | -$24.14 M |
| Net Profit Margin | -223.9% | -310.36% | -1858.29% | -71.12% | -567.86% | -713.48% |
Aktis Oncology, Inc. Common stock Financials Balance Sheet In USD
Quarterly
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $75.00 K | $99.00 K | $123.00 K | $154.00 K | $5.00 K | $5.00 K |
| Reserve & Surplus | -$306.40 M | -$329.70 M | -$438.51 M | -$444.93 M | -$175.13 M | -$199.78 M |
| Non-Current Liabilities | $43.83 M | $42.47 M | $42.47 M | $42.50 M | $42.78 M | $40.63 M |
| Current Liabilities | $14.28 M | $18.23 M | $84.37 M | $80.09 M | $27.91 M | $32.13 M |
| Total Liabilities | $58.11 M | $60.69 M | $126.83 M | $122.59 M | $70.69 M | $72.76 M |
| Fixed Assets | $70.07 M | $66.42 M | $25.47 M | $24.28 M | $15.29 M | $15.97 M |
| Current Assets | $26.02 M | $28.56 M | $36.77 M | $25.71 M | $543.94 M | $524.54 M |
| Total Assets | $111.88 M | $102.60 M | $69.74 M | $57.37 M | $576.80 M | $557.60 M |
Aktis Oncology, Inc. Common stock Cash Flow
Quarterly
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$15.71 M | -$23.31 M | -$108.80 M | -$6.42 M | -$18.32 M | -$24.14 M |
| Operating Cash Flow | -$11.34 M | -$7.79 M | -$8.11 M | -$12.53 M | -$24.24 M | -$20.59 M |
| Investing Cash Flow | -$1.63 M | -$291.00 K | $133.00 K | -$185.00 K | $20.54 M | -$268.71 M |
| Financing Cash Flow | $52.00 K | $10.41 M | $17.22 M | $333.00 K | $337.55 M | $156.00 K |
| Change in Cash | -$12.91 M | $2.33 M | $9.25 M | -$12.39 M | $333.85 M | -$289.14 M |
Aktis Oncology, Inc. Common stock Return Calculator
The Aktis Oncology, Inc. Common stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$22,424
Invested Amount$10,000
Est. Returns$12,424
About Aktis Oncology, Inc. Common stock
Aktis Oncology Inc is a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies. The company specializes in developing targeted alpha radiopharmaceuticals for solid tumors such as breast, lung, colorectal, bladder, and liver cancers. Its pipeline products include AKY-1189 and AKY-2519, focusing on solid tumors. The company has one operating and reportable segment focused on the research and development of targeted radiopharmaceuticals to treat a broad range of solid tumor cancers. The company generates revenue from Collaboration agreement.
Popular Stocks
FAQs
What is the share price of Aktis Oncology, Inc. Common stock today?
Aktis Oncology, Inc. Common stock (AKTS) share price as of September 18, 2026 is $22.20. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Aktis Oncology, Inc. Common stock?
Yes, Indian Investors can invest in the Aktis Oncology, Inc. Common stock (AKTS) Share by opening an international trading account with Angel One.
How can I purchase Aktis Oncology, Inc. Common stock shares in India?
Purchasing Aktis Oncology, Inc. Common stock (AKTS) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Aktis Oncology, Inc. Common stock (AKTS) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Aktis Oncology, Inc. Common stock?
Yes, you can purchase fractional shares of Aktis Oncology, Inc. Common stock (AKTS) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Aktis Oncology, Inc. Common stock?
The market capitalization of Aktis Oncology, Inc. Common stock on September 18, 2026, is $1.26 B.
In which sector Aktis Oncology, Inc. Common stock belongs?
Aktis Oncology, Inc. Common stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Aktis Oncology, Inc. Common stock stocks?
In order to invest in Aktis Oncology, Inc. Common stock (AKTS) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
